Synthesis, characterization and antimicrobial activity evaluation of new imidazo [2,1-b][1,3,4]thiadiazole derivatives

Shankar Gaddeppa Alegaon; Kallanagouda Ramappa Alagawadi

doi:10.5155/eurjchem.2.1.94-99.161

PDF

Published: Mar 28, 2011

DOI: https://doi.org/10.5155/eurjchem.2.1.94-99.161

Keywords:

Thiazolidinedione, Thiadiazole, Imidazo[2, 1-b][1, 3, 4]thiadiazoles, Antibacterial activity, Antifungal activity, Rhodanine

Section

Research Article

Issue

Vol. 2 No. 1 (2011): March 2011

Dates

Received 2010-06-09
Accepted 2010-10-11
Published 2011-03-28

Shankar Gaddeppa Alegaon

Department of Pharmaceutical Chemistry, Karnataka Lingayat Education University’s College of Pharmacy, Belgaum, Karnataka, IN-590010, India

Kallanagouda Ramappa Alagawadi

Department of Pharmaceutical Chemistry, Karnataka Lingayat Education University’s College of Pharmacy, Belgaum, Karnataka, IN-590010, India

Abstract

Imidazo[2,1-b][1,3,4]thiadiazoles (4a-g) were synthesized from 3,4,5-trimethoxy benzoic acid and thiosemicarbazide. Reaction of 4 with Vilsmeier-Haack reagent yielded imidazo [2,1-b][1,3,4] thiadiazole–5-carbaldehyde derivatives (5a-g). Obtained imidazo[2,1-b][1,3,4] thiadia zoles-5-carbaldehydes were subjected to Knoevenagel condensation with 2-(2,4-dioxothia zolidin-3-yl)acetic acid (1) and 2-(4-oxo-2-thioxothiazolidin-3-yl)acetic (2) in the presence of catalytic amount of piperidine and acetic acid to afford imidazo[2,1-b][1,3,4]thiadiazoles (6a-g) and (7a-g), respectively. The structures of the newly synthesized compounds were confirmed by IR, NMR and elemental analyses. All compounds were screened for their antibacterial and antifungal activities. Some of the compounds displayed good antibacterial and antifungal activity.

2_1_94_99_800

This Abstract was viewed 5239 times |

Article PDF downloaded 1189 times

How to Cite

(1)

Alegaon, S. G.; Alagawadi, K. R. Synthesis, Characterization and Antimicrobial Activity Evaluation of New Imidazo [2,1-b][1,3,4]thiadiazole Derivatives. Eur. J. Chem. 2011, 2, 94-99.

Links for Article

Crossref - Scopus - Google - European PMC

References

[1]. Tenover, F. C.; McDonald, L. C. Curr. Opin. Infect. Dis. 2005, 18, 300-305.
doi:10.1097/01.qco.0000171923.62699.0c
PMid:15985825

[2]. Pfeltz, R. F.; Wilkinson, B. J. Curr. Drug. Targets Infect. Disord. 2004, 4, 273-294.
doi:10.2174/1568005043340470
PMid:15578969

[3]. Roberts, M. C. Curr. Drug. Targets Infect. Disord. 2004, 4, 207-215.
doi:10.2174/1568005043340678
PMid:15379732

[4]. Dessen, A.; Di Guilmi, A. M.; Vernet, T.; Dideberg, O. Curr. Drug. Targets Infect. Disord. 2001, 1, 63-77.
doi:10.2174/1568005013343272
PMid:12455234

[5]. Muroi, H.; Nihei, K.; Tsujimoto, K, and Kubo, I. Bioorg. Med. Chem. 2004, 12, 583-587.
doi:10.1016/j.bmc.2003.10.046

[6]. Chopra, I.; Schofield, C.; Everett, M.; O’Neill, K.; Miller, K.; Wilcox, M. Lancet Infect, Dis. 2008, 8, 133-139.
doi:10.1016/S1473-3099(08)70018-5

[7]. Terzioglu, N.; Gursoy, A. Eur. J. Med. Chem. 2003, 38, 781-786.
doi:10.1016/S0223-5234(03)00138-7

[8]. Kolavi, G.; Hegde, V.; Khazi, I M.; Gadad, P. Bioorg. Med. Chem. 2006, 14, 3069-3080.
doi:10.1016/j.bmc.2005.12.020

[9]. Gadad, A. K.; Mahajanshetti, C. S.; Nimbalkar, S.; Raichurkar, A. Eur. J. Med. Chem. 2000, 35, 853-857.
doi:10.1016/S0223-5234(00)00166-5

[10]. Andotra, C. S.; Langer, T. C.; Kotha, A. J. Indian Chem Soc. 1997, 72, 125-127.

[11]. Kumar, P. Chinese J. Chem. 2010, 28, 250-254.
doi:10.1002/cjoc.201090061

[12]. Andreani, A.; Bonazzi, D.; Rambaldi, M.; Fabbri, G.; Rainsford, K. D. Eur. J. Med. Chem. 1982, 17, 271-274.

[13]. Bhovi, V. K.; Bodke, Y. D. Current Chem. Biol. 2010, 4, 145-150.

[14]. Khazi, I. A. M.; Mahajanshetti, C. S.; Gadad, A. K.; Tarnalli, A. D.; Sultanpur, C. M. Arzneimittelforschung. 1996, 46, 949-952.
PMid:8931885

[15]. Andreani, A.; Leonia, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Simon, W. A.; Senn-Bilfinger, J. Arzneimittelforschung. 2000, 50, 550-553.
PMid:10918949

[16]. Andreani, A.; Rambaldi, M.; Mascellani, G.; Bossa, R.; Galatulas, I. Eur. J. Med. Chem. 1986, 21, 451-453.

[17]. Andreani, A.; Rambaldi, M.; Mascellani, G.; Rugarli, P. Eur. J. Med. Chem. 1987, 22, 19-22.
doi:10.1016/0223-5234(87)90169-3

[18]. Andreani, A.; Rambaldi, M.; Locatelli, A.; Andreani, F. Collect. Czech. Chem. Commun. 1991, 56, 2436-2447.
doi:10.1135/cccc19912436

[19]. Terashima, H.; Hama, K.; Yamamoto, R.; Tsuboshima, M.; Kikkawa, I. and Shigata, Y. J. Pharmacol. Exp. Ther. 1984, 229, 226-230.

[20]. Yoshioka, T.; Fujita, T.; Kanai, T.; Aizawa,Y.; Kurumada, T.; Hasegawa, K.; Horikoshi, H. J. Med. Chem. 1989, 32, 421-428.
doi:10.1021/jm00122a022
PMid:2913302

[21]. Ayhan-Kilcigil, G.; Altanlar, N. Arzneimittelforschung. 2000, 50, 154-157.
PMid:10719619

[22]. Heerding, D. A.; Christmann, L. T.; Clark, T. J.; Holmes, D. J.; Rittenhouse, S. F.; Takata, D. T.; Venslavsky, J. W. Med. Chem. Lett. 2003, 13, 3771-3773.
doi:10.1016/j.bmcl.2003.07.010

[23]. Tuncbilek, M.; Altanlar N. Arch. Pharm. Chem. Life Sci. 2006, 339, 213-216.
doi:10.1002/ardp.200500180
PMid:16572478

[24]. Bozdag-Dundar, O.; Ozgen, O.; Mentese, A.; Altanlar, N.; Atli, O.; Kendi, E.; Ertan, R. Bioorg. Med. Chem. 2007, 15, 6012- 6017.
doi:10.1016/j.bmc.2007.06.049

[25]. Cantello, B. C. C.; Cawthorne, M. A.; Cottam, G. P.; Duff, P. T.; Haigh, D.; Hindley, R. M.; Lister, C. A.; Smith, S. A.; Thurlby, P. L. J. Med. Chem. 1994, 37, 3977-3985.
doi:10.1021/jm00049a017
PMid:7966158

[26]. Andreani, A.; Rambaldi, M.; Locatelli, A.; Leoin, A.; Bossa, R.; Chiericozzi, M.; Galatulas, I.; Salvatore, G. Eur. J. Med. Chem. 1993, 28, 825-829.
doi:10.1016/0223-5234(93)90118-X

[27]. De Lima, J. G.; Perrissin, M.; Chantegrel, J. Arzneimittelforschung. 1994, 44, 831-834.
PMid:7945517

[28]. Boschelli, D. H.; Connor, D. T.; Kuipers, P. J.; Wright, C. D. Bioorg. Med. Chem. Lett. 1992, 2, 705-708.
doi:10.1016/S0960-894X(00)80396-0

[29]. Al-Omar, M.; Al-Deeb, A.; Al-Khamees.; El-Emam, A. A. Phosphorus, Sulfur, and Silicon. 2004, 179, 2509-2517.
doi:10.1080/10426500490485525

[30]. Mazzone, G.; Bonina, F.; Puglisi, G.; Arrigo, R. R.; Cosentino, C.; Blandino, G. Farmaco Sci. 1982, 37, 685-700.
PMid:6982830

[31]. Maccari, R.; Ottana, R.; Curinga, C.; Vigorita, M. G.; Rakowitz, D.; Steindl, T.; Langer, T. Bioorg. Med. Chem. 2005, 13, 2809-2823.
doi:10.1016/j.bmc.2005.02.026

[32]. CLSI/NCCLS Guidelines: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; 7th Ed. Approved Standard document M-7:A5, Villanova, PA, NCCLS, 2006.

Supporting Agencies

Most read articles by the same author(s)

TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

License Terms

License Terms

by-nc

Copyright © 2025 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).

Article Sidebar

Main Article Content

Abstract

Article Details

Downloads

Metrics